Canada markets closed

Beximco Pharmaceuticals Limited (R2WA.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.4440+0.0040 (+0.91%)
At close: 08:20AM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
Cash flows from operating activities
Net Income
5,330,373
4,614,066
5,123,137
5,127,694
3,514,687
Depreciation & amortization
-
2,060,503
1,667,010
-
-
Change in working capital
-
-734,170
-1,909,440
-
-
Inventory
-
-1,828,926
-2,565,078
-
-
Other working capital
5,962,130
3,374,759
2,274,678
3,464,846
3,267,186
Net cash provided by operating activites
-
6,084,787
5,214,176
-
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,410,756
-2,710,028
-2,939,498
-2,558,418
-2,275,301
Acquisitions, net
-
0
-4,766,636
0
-
Sales/Maturities of investments
-
-
-
-
323,365
Net cash used for investing activites
-2,582,989
-2,617,018
-7,680,054
-2,524,646
-1,946,862
Net change in cash
130,235
-92,802
149,347
40,450
22,554
Cash at beginning of period
983,806
1,168,674
973,964
635,017
610,494
Cash at end of period
1,114,041
1,135,686
1,168,674
675,467
635,017
Free Cash Flow
Operating Cash Flow
-
6,084,787
5,214,176
-
-
Capital Expenditure
-2,410,756
-2,710,028
-2,939,498
-2,558,418
-2,275,301
Free Cash Flow
5,962,130
3,374,759
2,274,678
3,464,846
3,267,186